ABRUPT WITHDRAWAL OF BETA-BLOCKING-AGENTS IN PATIENTS WITH ARTERIAL-HYPERTENSION - EFFECT ON BLOOD-PRESSURE, HEART-RATE AND PLASMA-CATECHOLAMINES AND PROLACTIN

被引:50
作者
PEDERSEN, OL
MIKKELSEN, E
NIELSEN, JL
CHRISTENSEN, NJ
机构
[1] AARHUS KOMMUNE HOSP,INTERNAL MED 2 CLIN,AARHUS,DENMARK
[2] AARHUS AMTSSYGEHUS,DEPT INTERNAL MED 1,AARHUS,DENMARK
[3] AARHUS AMTSSYGEHUS,DEPT INTERNAL MED 2,AARHUS,DENMARK
[4] HERLEV HOSP,DEPT INTERNAL MED & ENDOCRINOL,AARHUS,DENMARK
关键词
arterial hypertension; beta-blocker withdrawal; beta-receptor sensitivity; catecholamines; metoprolol; prolactin; propranolol;
D O I
10.1007/BF00563108
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Chronic treatment with beta-blockers was interrupted abruptly in six patients with arterial hypertension. Three patients, who had experienced symptoms during a previous withdrawal, again complained of transient palpitations, tremor, sweating, headache and general malaise. A significant increase in standing blood pressure (BP) and heart rate (HR) was noted after 24 h. The standing HR reached a maximum after 48 h and had decreased significantly on the 7th day (p<0.005). There was a strong tendency to greater increase in standing BP and HR in the patients who experienced symptoms than in those who did not. Plasma concentrations of noradrenaline, adrenaline and prolactin did not change significantly. Thus, beta-blocker withdrawal symptoms are reproducible and are indicative of a transient sympathetic hyperresponse. The increased activity is not likely to be caused by increased production of circulating catecholamines, but rather by increased sensitivity of the beta-receptor. © 1979 Springer-Verlag.
引用
收藏
页码:215 / 217
页数:3
相关论文
共 11 条
  • [1] HYPERSENSITIVITY TO ADRENERGIC-STIMULATION AFTER PROPRANOLOL WITHDRAWAL IN NORMAL SUBJECTS
    BOUDOULAS, H
    LEWIS, RP
    KATES, RE
    DALAMANGAS, G
    [J]. ANNALS OF INTERNAL MEDICINE, 1977, 87 (04) : 433 - 436
  • [2] PLASMA NORADRENALINE AND ADRENALIN IN PATIENTS WITH THYROTOXICOSIS AND MYXEDEMA
    CHRISTENSEN, NJ
    [J]. CLINICAL SCIENCE AND MOLECULAR MEDICINE, 1973, 45 (02): : 163 - 171
  • [3] HANSSEN T, 1978, LANCET, V1, P101
  • [4] KRISTENSEN BO, 1978, CLIN PHARMACOL THER, V23, P624
  • [5] KRISTENSEN BO, 1977, CLIN PHARMACOL THER, V22, P864
  • [6] LEDERBALLEPEDER.O, 1976, EUR J CLIN PHARMACOL, V10, P381
  • [7] PROPRANOLOL-WITHDRAWAL REBOUND PHENOMENON - EXACERBATION OF CORONARY EVENTS AFTER ABRUPT CESSATION OF ANTIANGINAL THERAPY
    MILLER, RR
    OLSON, HG
    AMSTERDAM, EA
    MASON, DT
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1975, 293 (09) : 416 - 418
  • [8] OBRIEN ET, 1972, BRIT HEART J, V34, P1042
  • [9] REID JL, 1977, LANCET, V1, P1171
  • [10] HOMOLOGOUS RADIOIMMUNOASSAY FOR HUMAN PROLACTIN
    REUTER, AM
    KENNES, F
    GEVAERT, Y
    FRANCHIMONT, P
    [J]. INTERNATIONAL JOURNAL OF NUCLEAR MEDICINE & BIOLOGY, 1976, 3 (01): : 21 - 28